Apyx Medical
Apyx Medical is an advanced energy technology company known for its Renuvion® and J-Plasma® helium plasma technologies, headquartered in Clearwater, FL.
Apyx Medical Services
Apyx Medical offers a range of innovative products and services in the surgical market, focusing on advanced energy technologies. The company's key technologies include Renuvion® and J-Plasma®. Apyx Medical provides high-quality equipment for both open and minimally invasive surgical procedures. They also offer a diverse collection of generators and handpieces designed to enhance surgical precision and patient outcomes.
Apyx Medical Products
Apyx Medical's notable products include the Renuvion® and J-Plasma® helium plasma technologies. Renuvion® is FDA-cleared for use after liposuction and for contracting subcutaneous tissue, as well as wrinkle reduction procedures. The J-Plasma® system combines helium plasma with a proprietary RF waveform to create a precise tissue effect and is used in open, laparoscopic, and robotic procedures. Additionally, the company offers the Apyx One Console and various other electrosurgical generators supported by a four-year warranty.
Apyx Medical's History
Apyx Medical, formerly known as Bovie® Medical, has a long history rooted in expertise in unique waveforms. The company has grown from its original focus to become a significant player in advanced energy technology solutions, particularly within the surgical field. Apyx Medical continues to expand its product offerings and capabilities, demonstrating a commitment to innovation and excellence in medical technology.
Apyx Medical Headquarters and Facilities
Apyx Medical's headquarters is located in Clearwater, Florida, USA. The company also operates a manufacturing facility and a European Authorized Service Center in Bulgaria. These facilities play a crucial role in the design, production, and servicing of Apyx Medical's advanced surgical devices, ensuring high standards of quality and reliability for their global client base.
Apyx Medical Financial Performance
Apyx Medical reported total revenue of $10.2 million for the first quarter of 2024. The company's OEM segment experienced a notable increase, with year-over-year revenue growth of 14% for the same period. Apyx Medical reaffirmed its financial guidance for the full year ending December 31, 2024, indicating a steady and optimistic outlook for its future performance. Their financial success is supported by OEM agreements with other medical device manufacturers and a strong portfolio of over 90 clinical documents.